{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T19:33:04Z","timestamp":1790019184441,"version":"4.0.1"},"reference-count":55,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,19]],"date-time":"2024-08-19T00:00:00Z","timestamp":1724025600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009946","name":"Allergopharma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009946","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jaci-inpractice.org","clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.jaip.2024.08.025","type":"journal-article","created":{"date-parts":[[2024,8,23]],"date-time":"2024-08-23T07:23:51Z","timestamp":1724397831000},"page":"17-23","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Risk Factors for Severe Sting Reactions and Side Effects During Venom Immunotherapy"],"prefix":"10.1016","volume":"13","author":[{"given":"Gunter J.","family":"Sturm","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6110-520X","authenticated-orcid":false,"given":"Eva","family":"Schadelbauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgia","family":"Marta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrizia","family":"Bonadonna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitja","family":"Kosnik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaip.2024.08.025_bib1","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1097\/ACI.0b013e32830638c5","article-title":"Epidemiology of insect-venom anaphylaxis","volume":"8","author":"Bilo","year":"2008","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.08.025_bib2","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1111\/j.1398-9995.2011.02659.x","article-title":"Prevalence of hymenoptera venom allergy and poor adherence to immunotherapy in Austria","volume":"66","author":"Bokanovic","year":"2011","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2024.08.025_bib3","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1046\/j.1365-2222.1999.00614.x","article-title":"Epidemiological study of the prevalence of allergic reactions to Hymenoptera in a rural population in the Mediterranean area","volume":"29","author":"Fernandez","year":"1999","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaip.2024.08.025_bib4","first-page":"372","article-title":"Prevalence of allergic reactions to Hymenoptera stings in northern Italy","volume":"36","author":"Incorvaia","year":"2004","journal-title":"Eur Ann Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.08.025_bib5","first-page":"1","article-title":"Updates and recent advances on venom immunotherapy","author":"Floyd","year":"2023","journal-title":"Curr Treat Options Allergy"},{"key":"10.1016\/j.jaip.2024.08.025_bib6","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/j.jaci.2009.08.027","article-title":"Predictors of severe systemic anaphylactic reactions in patients with Hymenoptera venom allergy: importance of baseline serum tryptase\u2014a study of the European Academy of Allergology and Clinical Immunology Interest Group on Insect Venom Hypersensitivity","volume":"124","author":"Rueff","year":"2009","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.08.025_bib7","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1111\/all.13945","article-title":"Risk factors and indicators of severe systemic insect sting reactions","volume":"75","author":"Stoevesandt","year":"2020","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2024.08.025_bib8","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1111\/all.12967","article-title":"Hymenoptera stings in the head region induce impressive, but not severe sting reactions","volume":"71","author":"Arzt","year":"2016","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2024.08.025_bib9","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S0140-6736(00)03647-3","article-title":"Constitutively raised serum concentrations of mast-cell tryptase and severe anaphylactic reactions to Hymenoptera stings","volume":"357","author":"Ludolph-Hauser","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.jaip.2024.08.025_bib10","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1111\/j.1398-9995.2010.02470.x","article-title":"Influence of total and specific IgE, serum tryptase, and age on severity of allergic reactions to Hymenoptera stings","volume":"66","author":"Blum","year":"2011","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2024.08.025_bib11","doi-asserted-by":"crossref","first-page":"3157","DOI":"10.1016\/j.jaip.2021.04.045","article-title":"Biomarkers of the severity of honeybee sting reactions and the severity and threshold of systemic adverse events during immunotherapy","volume":"9","author":"Kopa\u010d","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2024.08.025_bib12","doi-asserted-by":"crossref","first-page":"162","DOI":"10.18176\/jiaci.0363","article-title":"Basal tryptase levels can predict clinical severity in Hymenoptera venom anaphylaxis and ischemic cardiovascular disorders","volume":"29","author":"Farioli","year":"2019","journal-title":"J\u00a0Investig Allergol Clin Immunol"},{"key":"10.1016\/j.jaip.2024.08.025_bib13","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.jaci.2021.02.043","article-title":"Routine KIT p.D816V screening identifies clonal mast cell disease in patients with Hymenoptera allergy regularly missed using baseline tryptase levels alone","volume":"148","author":"\u0160elb","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.08.025_bib14","doi-asserted-by":"crossref","first-page":"2458","DOI":"10.1111\/all.16084","article-title":"High burden of clonal mast cell disorders and hereditary \u03b1-tryptasemia in patients who need Hymenoptera venom immunotherapy","volume":"79","author":"Koro\u0161ec","year":"2024","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2024.08.025_bib15","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1038\/s41375-022-01613-1","article-title":"The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic\/Dendritic Neoplasms","volume":"36","author":"Khoury","year":"2022","journal-title":"Leukemia"},{"key":"10.1016\/j.jaip.2024.08.025_bib16","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.jaci.2014.11.035","article-title":"Clonal mast cell disorders in patients with severe Hymenoptera venom allergy and normal serum tryptase levels","volume":"136","author":"Zanotti","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.08.025_bib17","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1159\/000329856","article-title":"Validation of the REMA score for predicting mast cell clonality and systemic mastocytosis in patients with systemic mast cell activation symptoms","volume":"157","author":"Alvarez-Twose","year":"2012","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.jaip.2024.08.025_bib18","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1111\/all.13380","article-title":"Factors increasing the risk for a severe reaction in anaphylaxis: an analysis of data from The European Anaphylaxis Registry","volume":"73","author":"Worm","year":"2018","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2024.08.025_bib19","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1038\/s41375-021-01406-y","article-title":"Refined diagnostic criteria for bone marrow mastocytosis: a proposal of the European competence network on mastocytosis","volume":"36","author":"Zanotti","year":"2022","journal-title":"Leukemia"},{"key":"10.1016\/j.jaip.2024.08.025_bib20","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1016\/j.jaip.2023.04.016","article-title":"Venom anaphylaxis: decision points for a more aggressive workup","volume":"11","author":"Bonadonna","year":"2023","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2024.08.025_bib21","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1038\/ng.3696","article-title":"Elevated basal serum tryptase identifies a multisystem disorder associated with increased TPSAB1 copy number","volume":"48","author":"Lyons","year":"2016","journal-title":"Nat Genet"},{"key":"10.1016\/j.jaip.2024.08.025_bib22","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.anai.2021.01.016","article-title":"Hereditary alpha-tryptasemia in 101 patients with mast cell activation-related symptomatology including anaphylaxis","volume":"126","author":"Giannetti","year":"2021","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2024.08.025_bib23","doi-asserted-by":"crossref","first-page":"3549","DOI":"10.1016\/j.jaip.2020.05.057","article-title":"Hereditary alpha-tryptasemia: UK prevalence and variability in disease expression","volume":"8","author":"Robey","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2024.08.025_bib24","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.jaci.2020.06.035","article-title":"Heritable risk for severe anaphylaxis associated with increased alpha-tryptase-encoding germline copy number at TPSAB1","volume":"147","author":"Lyons","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.08.025_bib25","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1182\/blood.2020006157","article-title":"Hereditary \u03b1 tryptasemia is a valid genetic biomarker for severe mediator-related symptoms in mastocytosis","volume":"137","author":"Greiner","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.jaip.2024.08.025_bib26","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1111\/all.15911","article-title":"Clinical impact of the TPSAB1 genotype in mast cell diseases: a REMA study in a cohort of 959 individuals","volume":"79","author":"Gonz\u00e1lez-de-Olano","year":"2024","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2024.08.025_bib27","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1111\/all.14785","article-title":"beta-blockers and ACE inhibitors are not a risk factor for severe systemic sting reactions and adverse events during venom immunotherapy","volume":"76","author":"Sturm","year":"2021","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2024.08.025_bib28","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/j.jaci.2014.10.021","article-title":"Increase in anaphylaxis-related hospitalizations but no increase in fatalities: an analysis of United Kingdom national anaphylaxis data, 1992-2012","volume":"135","author":"Turner","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.08.025_bib29","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1111\/j.1398-9995.2009.02302.x","article-title":"Basal serum tryptase as risk assessment for severe Hymenoptera sting reactions in elderly","volume":"65","author":"Guenova","year":"2010","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2024.08.025_bib30","first-page":"65","article-title":"Basal serum tryptase level correlates with severity of hymenoptera sting and age","volume":"17","author":"Kucharewicz","year":"2007","journal-title":"J\u00a0Investig Allergol Clin Immunol"},{"key":"10.1016\/j.jaip.2024.08.025_bib31","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0091-6749(05)80012-0","article-title":"Natural history of insect sting allergy: relationship of severity of symptoms of initial sting anaphylaxis to re-sting reactions","volume":"90","author":"Reisman","year":"1992","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.08.025_bib32","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1056\/NEJMoa022952","article-title":"Outcomes of allergy to insect stings in children, with and without venom immunotherapy","volume":"351","author":"Golden","year":"2004","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2024.08.025_bib33","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/j.jaci.2012.03.024","article-title":"Over- and underestimated parameters in severe Hymenoptera venom-induced anaphylaxis: cardiovascular medication and absence of urticaria\/angioedema","volume":"130","author":"Stoevesandt","year":"2012","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.08.025_bib34","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1053\/ai.1994.v94.a54889","article-title":"Insect-sting challenge in 324 subjects with a previous anaphylactic reaction: current criteria for insect-venom hypersensitivity do not predict the occurrence and the severity of anaphylaxis","volume":"94","author":"van der Linden","year":"1994","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.08.025_bib35","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.jaci.2004.04.029","article-title":"Clinical features and severity grading of anaphylaxis","volume":"114","author":"Brown","year":"2004","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.08.025_bib36","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.jaci.2014.09.004","article-title":"Ramipril and metoprolol intake aggravate human and murine anaphylaxis: evidence for direct mast cell priming","volume":"135","author":"Nassiri","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.08.025_bib37","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/S1081-1206(10)60714-4","article-title":"Fatal anaphylaxis: postmortem findings and associated comorbid diseases","volume":"98","author":"Greenberger","year":"2007","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2024.08.025_bib38","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1097\/ACI.0b013e328259c328","article-title":"Cardiovascular disease and anaphylaxis","volume":"7","author":"Mueller","year":"2007","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.08.025_bib39","first-page":"1887","article-title":"Fatalities from insect stings in Switzerland 1978 to 1987","volume":"124","author":"Sasvary","year":"1994","journal-title":"Schweiz Med Wochenschr"},{"key":"10.1016\/j.jaip.2024.08.025_bib40","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1159\/000341666","article-title":"Clinical features of children with venom allergy and risk factors for severe systemic reactions","volume":"160","author":"Yavuz","year":"2013","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.jaip.2024.08.025_bib41","series-title":"Insect Sting Allergy","author":"Muller","year":"1990"},{"key":"10.1016\/j.jaip.2024.08.025_bib42","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1111\/j.1398-9995.2007.01413.x","article-title":"Influence of total IgE levels on the severity of sting reactions in Hymenoptera venom allergy","volume":"62","author":"Sturm","year":"2007","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2024.08.025_bib43","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1016\/j.jaci.2013.10.046","article-title":"Sensitization to Hymenoptera venoms is common, but systemic sting reactions are rare","volume":"133","author":"Sturm","year":"2014","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.08.025_bib44","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1067\/mai.2002.129124","article-title":"Rush Hymenoptera venom immunotherapy: a safe and practical protocol for high-risk patients","volume":"110","author":"Sturm","year":"2002","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.08.025_bib45","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.jaci.2009.05.026","article-title":"The safety of initiating Hymenoptera immunotherapy at 1 microg of venom extract","volume":"124","author":"Roumana","year":"2009","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.08.025_bib46","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1034\/j.1398-9995.2000.00587.x","article-title":"Side-effects of insect venom immunotherapy: results from an EAACI multicenter study. European Academy of Allergology and Clinical Immunology","volume":"55","author":"Mosbech","year":"2000","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2024.08.025_bib47","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jaci.2010.04.025","article-title":"Predictors of side effects during the buildup phase of venom immunotherapy for Hymenoptera venom allergy: the importance of baseline serum tryptase","volume":"126","author":"Rueff","year":"2010","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.08.025_bib48","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1111\/cea.12582","article-title":"Immunological and clinical factors associated with adverse systemic reactions during the build-up phase of honeybee venom immunotherapy","volume":"45","author":"Korosec","year":"2015","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaip.2024.08.025_bib49","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1111\/all.13262","article-title":"EAACI guidelines on allergen immunotherapy: Hymenoptera venom allergy","volume":"73","author":"Sturm","year":"2018","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2024.08.025_bib50","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/S0091-6749(05)80182-4","article-title":"The Hymenoptera venom study, III: safety of venom immunotherapy","volume":"86","author":"Lockey","year":"1990","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.08.025_bib51","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1111\/cea.12276","article-title":"Angiotensin-converting enzyme inhibitors do not impair the safety of Hymenoptera venom immunotherapy build-up phase","volume":"44","author":"Stoevesandt","year":"2014","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaip.2024.08.025_bib52","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1111\/all.14012","article-title":"A\u00a0safe and efficient 7-week immunotherapy protocol with aluminum hydroxide adsorbed vespid venom","volume":"75","author":"Schrautzer","year":"2020","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2024.08.025_bib53","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1067\/mai.2000.105708","article-title":"Safety of a two-day ultrarush insect venom immunotherapy protocol in comparison with protocols of longer duration and involving a larger number of injections","volume":"105","author":"Brehler","year":"2000","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.08.025_bib54","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0091-6749(05)80105-8","article-title":"Risk of systemic reactions in patients taking beta-blocker drugs receiving allergen immunotherapy injections","volume":"86","author":"Hepner","year":"1990","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.08.025_bib55","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.jaci.2004.11.012","article-title":"Use of beta-blockers during immunotherapy for Hymenoptera venom allergy","volume":"115","author":"Muller","year":"2005","journal-title":"J\u00a0Allergy Clin Immunol"}],"container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219824008456?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219824008456?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T06:07:19Z","timestamp":1736316439000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213219824008456"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":55,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["S2213219824008456"],"URL":"https:\/\/doi.org\/10.1016\/j.jaip.2024.08.025","relation":{},"ISSN":["2213-2198"],"issn-type":[{"value":"2213-2198","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risk Factors for Severe Sting Reactions and Side Effects During Venom Immunotherapy","name":"articletitle","label":"Article Title"},{"value":"The Journal of Allergy and Clinical Immunology: In Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaip.2024.08.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology.","name":"copyright","label":"Copyright"}]}}